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To date, the major role of HPV16E6 in cancer has been considered to be its ability to inhibit the p53 tumor-suppressor protein,
thereby thwarting p53-mediated cytotoxic responses to cellular stress signals. Here, we show that HPV16E6-dependent c-fos onco-
genic protein expression contributes to AP-1 complex formation under oxidative stress in SiHa cells (HPV16-positive squamous
cell carcinoma of the cervix). In addition, we examined the role of HPV16E6 in TGF-α-induced c-fos expression and found that
the c-fos protein expression induced by TGF-α is HPV16E6 dependent. Thus, our results provide the ﬁrst evidence that HPV16E6
contributes to AP-1 complex formation after both ligand-dependent and independent EGFR activation, suggesting a new thera-
peutic approach to the treatment of HPV-associated tumors.
1.Introduction
HPV(humanpapillomavirus)infectionisahallmarkofuter-
ine cervical cancer and is thought to be important, if not
causal, for some types of tumorigenesis [1–3]. Two HPV-
encoded proteins, E6 and E7, inactivate and inhibit the ex-
pression of the p53 and RB tumor suppressor proteins,
respectively. Nevertheless, HPV infection is not suﬃcient for
tumorigenesis, because HPV infection is also present in
healthy individuals [4], and the overexpression of E6/E7
alone is capable of immortalizing primary human epithelial
cells but does not induce tumor cell transformation [5].
Thus, understanding the conditions that stimulate HPV-
infected cells is crucial for the development of eﬀective treat-
ments for HPV-associated tumors.
The transcription factor AP-1, which is composed of het-
erodimers of members of the c-Jun and c-Fos families, reg-
ulates various cellular processes such as enhanced prolifer-
ation, apoptosis, and tumor metastasis [6]. In particular,
among the various members of the AP-1 family, c-fos acts
as a tumor promoter, and c-fos upregulation causes cellular
transformation that is characterized by colony formation in
soft-agar and tumor formation in nude mice [7, 8]. In ad-
dition, when c-fos binds to c-jun, it increases the gene
expression of cyclinD1 and contributes to the potentiation
of malignancy [9–11].
In cervical cancer, the AP-1 complex formed during
tumor development consists of a c-fos/c-jun heterodimer
[9, 12–14], and c-fos/c-jun formation is also implicated in
HPV-induced esophageal tumor development [15]. In fact,
various c-fos target genes are reported to be expressed at
higher levels in cervical cancer cells with comparison to
normal cervical epithelial cells [16]. While c-fos showed very
low expression in normal samples and moderate expression
in cervical premalignant lesions, the tumor tissues showed
very strong expression [13]. It is, therefore, reasonable to
assume that c-fos regulation plays a fundamental role in
HPV-induced tumor development. However, the extracellu-
lar conditions in which c-fos expression and AP-1 complex
formation are induced in HPV-infected cells are unknown.2 Mediators of Inﬂammation
A shift in the composition of AP-1 from fra-1/c-jun to
c-fos/c-jun heterodimers occurs during HPV-infected tumor
development [7, 14]. The same shift in AP-1 composition
also takes place under oxidative stress, such as after UV-B
exposure [10]. As transient transfection experiments showed
that HPV16E6 induces the transcription of the c-fos pro-
moter [17], we hypothesized that under oxidative stress
HPV16E6 function might contribute to c-fos expression and
c-fos/c-jun heterodimer formation.
There are at least 15 cancer-associated HPV types, and of
these, HPV16 is found in more than 50% of HPV-positive
cancer tissues [1, 2]. Here, we used SiHa cells (HPV16-
positive squamous cell carcinoma of the cervix) and showed
that H2O2 and TGF-α, which are promoters of the multistep
carcinogenic process [18, 19], induced c-fos/c-jun heter-
odimer formation in SiHa cells, whereas o-phenanthroline
inhibited H2O2-induced c-fos upregulation. H2O2 and TGF-
α-induced c-fos upregulation was impaired in SiHa cells
transfected with siRNA HPV16E6. This result further impli-
catesH2O2 and TGF-α signaling in the pathogenesis of HPV-
induced tumor development.
2.MaterialandMethods
2.1. Reagents. H2O2 was purchased from WAKO (Tokyo,
Japan), and o-phenanthroline was obtained from Sigma-
Aldrich (S.t. Louis, Mo, USA).
2.2. Cell Culture and Treatment. The SiHa and Caski cell
line used in our study was obtained from the American
Type Culture Collection. SiHa cells were routinely cultured
in DMEM (Invitrogen) supplemented with 5% fetal bovine
serum (Sigma) at 37◦C under 5% CO2.S i H ac e l l sw e r e
serum-deprived for at least 16 hours before being stimulated
with H2O2 (1mM). To observe the eﬀect of an Fe2+ chelating
agent on the activation of c-fos, o-phenanthroline (0.2mM)
was added to the culture medium 1 hour before stimulation
with H2O2.
2.3. SDS–PAGE and Western Blotting. The cell cultures (80–
100% conﬂuent) were washed twice with ice-cold phosphate
buﬀered saline and lysed in 1 × Laemmli sample buﬀer sup-
plemented with a protease inhibitor cocktail (Roche) and
a phosphatase inhibitor cocktail (Roche). The cells were
scraped and homogenized at 4◦C with a syringe and a thin
needle, and the cell lysates were subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE, 10%
resolvinggel).Theresultantproteinswereelectrophoretically
transferred onto nitrocellulose membranes (Pall Corpora-
tion), before being incubated for 2h at room temperature
with blocking buﬀer containing 4% nonfat dried milk in
TBS (20mM Tris (pH 7.6) and 150mM NaCl). They were
then washed with TBS-T (0.1% Tween-20) and incubated
overnight at 4◦Ci nT B Sb u ﬀer containing 4% BSA (Wako)
and appropriate antibodies. The antibodies used in the
experiment were anti-c-fos (Santa Cruz, sc-52, 1:500)
and anti-c-jun (Cell Signaling, L70B11, 1:500), and the
secondary antibodies were Donkey Antirabbit IgG/HRP
(Amersham NA934, 1:5000) and Goat Antimouse IgG/HRP
(Chemicon, AP124P 1:5000).
The protein bands were visualized using an enhanced
chemiluminescence (ECL) detection system (GE Healthcare
Bio-Sciences). The signals from the membrane were detected
and imaged using a LAS-4000 imager (Fujiﬁlm Corpora-
t i o n ) .T h em e m b r a n e sw e r et h e ns t r i p p e d( 3 0m i na t5 6 ◦C)
in stripping buﬀer containing 100mM 2-mercaptoethanol,
2% SDS, and 62.5mM Tris–HCl (pH 6.7) and reprobed with
β-actin or tubulin as a loading control. All Western blots
were performed at least three times for each experiment.
To quantify the Western blot data, densitometric analysis
of ECL-exposed blots was performed using the NIH ImageJ
software (version 1.45f).
2.4. CoIP Assay. The antibodies used for the Western blot
analysis were c-Fos, c-Jun, and CBP/β. For the c-Fos coIP
assay,SiHacellswerelysedinamodiﬁedRIPAbuﬀer(50mM
Tris-HCl (pH 7.4), 150mM NaCl, 1mM EDTA, and 1%
NP-40) and a protease inhibitor mixture (Roche). CoIP was
performed using 2μg of the c-Fos antibody or the respective
isotype control.
2.5. Preparation of Small Interfering RNA and Transfection.
Synthesized siRNA duplexes were obtained from Invitro-
gen. The siRNA sequences targeting HPV16E6 correspond-
ed to nucleotides 5 -ACCGUUGUGUGAUUUGUUATT-3 
(siRNA1-HPV16E6) and 5 -UAACAAAUCACACAACGG-
UTT-3  (siRNA2-HPV16E6) of the coding region [20]. The
sequence of the negative control (siRNA-scrambled) was
as follows: 5 -CCAUUCCGAUCCUGAUCCGTT-3  and 5 -
CGGAUCAGGAUCGGAAUGGTT-3 . Cells in the exponen-
tial growth phase were plated in a 35mm dish containing
antibiotic-free medium at 30% conﬂuence and then trans-
fected with siRNA (siRNA-HPV16E6 or siRNA-scrambled)
using Oligofectamine (Invitrogen) and Opti-MEM I (Invit-
rogen), according to the manufacturer’s protocol. Silencing
was examined 24h after transfection.
2.6. RT-PCR. Total RNA were extracted from the har-
vested cells using Isogen (Nippon Gene). After the removal
of genomic DNA, approximately 1μg of RNA was used
to generate cDNA using Reverse Transcriptase M-MLV
(RNase H-) (TaKaRa) and random hexamers (Fermen-
tas). The primer sequences used were as follows: 5 -
CGGAATTCATGCACCAAAAGCGAAC-3  (sense) and 5 -
CCCAAGCTTACAGCTGGGTTTCTCT-3  (antisense) for
HPV16E6 [21]a n d5  -CAGGGCTGCTTTTAACTCTG-3 
(sense) and 5 -GATGATCTTGAGGCTGTTGTC-3  (anti-
sense) for GAPDH. The PCR reactions for HPV16E6 were
run for 30 cycles. GAPDH ampliﬁcation products were
used as a loading control. All ampliﬁcation products were
separated in 2% agarose gels. All RT-PCR were performed
at least three times for each experiment.
2.7. Statistical Analysis. Data are expressed as the mean ±
s.e.m. The paired-sample t-test was performed for statistical
comparisons. For all tests, a P value of less than 0.05 was
considered to be signiﬁcant.Mediators of Inﬂammation 3
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Figure 1: (a) Upregulation of AP-1 gene expression in SiHa cells at the indicated time points after H2O2(1mM) exposure. Representative
blots are shown and include β-actin or tubulin as a loading control, along with the results of densitometric analysis (0h, 4h; normalized to
β-actin or tubulin). ∗P<0.05, n = 3. (b) Inhibitory eﬀect of o-phenanthroline on H2O2-induced c-fos upregulation. Cells were pretreated
for 1hour with or without o-phenanthroline (200μM) before H2O2 (1mM) exposure. Representative blots are shown and include β-actin
as a loading control, along with the results of densitometric analysis (4h; normalized to β-actin). ∗P<0.05, n = 4.
3. Results
3.1.o-phenanthrolineInhibitsH2O2-Inducedc-FosExpression.
The upregulation of c-fos has been observed after H2O2
treatment in both epithelial and endothelial cells [19, 22],
which raises the possibility that SiHa cells might respond to
H2O2 in a similar manner. To test this, we analyzed c-fos
protein expression after H2O2 treatment in SiHa cells.
Western blotting analysis revealed aberrantly high levels of
c-fos protein expression after H2O2treatment (Figure 1(a)).
In the H2O2-treated SiHa cells, the expression of the AP-
1 family member c-jun was also upregulated (Figure 1(a)).
o-phenanthroline is an iron chelator [23] that protects cells
from cancer progression by inhibiting the Fenton reaction,4 Mediators of Inﬂammation
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Figure 2: (a) c-fos upregulation in SiHa cells after TGF-α (100ng/mL) treatment. Cells were harvested at the indicated time points and used
for Western blotting analysis. Representative blots are shown and include β-actin as a loading control, along with the results of densitometric
analysis (0h, 4h; normalized to β-actin). ∗P<0.01, n = 3. (b) IP of c-fos was performed using whole-cell extracts. Coprecipitated proteins
were detected by Western blotting analysis using antibodies speciﬁc to c-jun.
and it has been reported that in a mouse model of gastric
cancer the intraperitoneal injection of o-phenanthroline sig-
niﬁcantly reduced the incidence of gastric cancers [24]b y
inhibiting the Fenton reaction. The eﬀect of o-phenanthro-
line on c-fos expression in SiHa cells is unclear; therefore,
we tested the eﬀect of o-phenanthroline on H2O2-induced c-
fos expression in SiHa cells by pre-treating SiHa cells with o-
phenanthroline before H2O2treatment. As a result, we found
that o-phenanthroline markedly inhibited H2O2-induced c-
fos expression (Figure 1(b)).
3.2. Characterization of c-Fos/c-jun Heterodimers after Ligand
-Dependent and Independent EGFR Activation. The upregu-
lation of c-fos observed in epithelial cells after H2O2 treat-
ment is mainly mediated through EGFR activation [18]. We,
therefore, examined c-fos protein expression in SiHa cells
that had been treated with the EGFR ligand TGF-α.W e s t e r n
blotting analysis revealed aberrantly high levels of c-fos
protein expression after TGF-α treatment (Figure 2(a)). We
then investigated c-fos/c-jun heterodimer formation in SiHa
cells. We stimulated SiHa cells with H2O2 or TGF-α for
4 hours, immunoprecipitated c-fos, and determined its part-
ner AP-1 family member by Western blotting (Figure 2(b)).
Interactions between c-fos and c-jun were observed after
both H2O2 and TGF-α stimulation (Figure 2(b): the IP with
isotype control did not show any speciﬁc band).
3.3. HPV16E6 Mediates H2O2 and TGF-α-Induced c-Fos Ex-
pression. We next tested whether HPV16E6 is necessary for
the c-fos expression induced by H2O2 or TGF-α treatment.
To directly address the role of HPV16E6 protein in c-fos
expression, we transfected SiHa cells with siRNA HPV16E6
(Figure 3(a)). A scrambled nonspeciﬁc siRNA duplex was
used as a negative control. We observed siRNA HPV16E6-
dependent reductions in H2O2 and TGF-α induced c-fos
expression(Figures3(b)and3(c)).SimilarresultsthatsiRNA
HPV16E6-dependent reduction in c-fos expression induced
by H2O2 treatment were obtained in another cervical cancer
cell line, Caski cell (Figure 3(d)). These data suggest that
HPV16E6 is necessary for H2O2 and TGF-α induced-c-fos
expression.
4. Discussion
Our ﬁndings provide new insights into the mechanism of
c-fos/c-jun heterodimer formation during the development
of cervical cancer. First, our ﬁndings show that c-fos/c-
jun heterodimer formation results from both H2O2 andMediators of Inﬂammation 5
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Figure 3: HPV16E6-mediated upregulation of c-fos in SiHa cells. (a) The mRNA levels of HPV16E6 were detected by RT-PCR after
HPV16E6 siRNA transfection into SiHa cells. Cells were transfected with scrambled siRNA or HPV16E6 siRNA for 24 hours. (b) HPV16E6-
mediated upregulation of c-fos expression in SiHa cells after H2O2 exposure. The transfected cells were exposed to H2O2 (1mM) and
harvestedattheindicatedtimepoints,beforebeingsubjectedtoWesternblottinganalysis.Representativeblotsareshownandincludeβ-actin
as a loading control, along with the results of densitometric analysis (4h; normalized to β-actin). ∗P<0.05, n = 4. (c) HPV16E6-mediated
upregulation of c-fos expression in SiHa cells after TGF-α exposure. Transfected cells were exposed to TGF-α (100ng/mL) and harvested
at the indicated time points, before being subjected to Western blotting analysis. Representative blots are shown and include β-actin as a
loading control, along with the results of densitometric analysis (4h; normalized to β-actin). ∗P<0.05, n = 4. (d) HPV16E6-mediated
upregulation of c-fos expression in Caski cells after H2O2 exposure. The transfected cells were exposed to H2O2 (1mM) and harvested at the
indicated time points, before being subjected to Western blotting analysis.
TGF-α stimulation. The current view is that in cervical
cancer c-fos/c-jun heterodimer formation results from the
ineﬃcient expression of the ternary complex factor Net [25],
buttheevidencewehaveuncoveredforHPV16E6dependent
c-fos expression after H2O2 or TGF-α stimulation broadens
the scope of the mechanisms of c-fos/c-jun heterodimer
formationinextracellularconditions suchasoxidative stress.
For example, the observed shift in AP-1 composition from
fra-1/c-jun to c-fos/c-jun heterodimers in HaCaT kerat-
inocytes after UV-B exposure [10] suggests that after being6 Mediators of Inﬂammation
induced by extracellular and environmental stimuli, c-fos
expression and c-fos/c-jun heterodimer formation con-
tribute to the pathological process of HPV positive skin
cancer.Therefore,studiesofc-fosexpression,HPVinfection,
and skin tumor development are necessary.
Second, our data indicate that HPV16E6 is necessary
andsuﬃcientforc-fos/c-junheterodimerformationtooccur
in SiHa cells under both H2O2 and TGF-α stimulation. In
the presence of transition metals such as iron and copper,
H2O2 can be oxidized into extremely reactive and toxic
HO• via the Fenton reaction. The hydroxyl radical (HO•)
then activates EGFR [26]. Our data show that H2O2 and
TGF-α are stimulators of c-fos/c-jun heterodimer formation
and conﬁrm that the iron chelator is an inhibitor of c-fos
expression that acts by inhibiting the Fenton reaction. The
negative eﬀect of o-phenanthroline on HPV16E6 mediated
c-fos expression might explain why iron chelation inhibits
growth and induces the apoptosis of HPV-positive carci-
noma cells [27]. Tumorigenic cervical cells express higher
levels of intracellular iron [28], which creates an envi-
ronment that favors HPV16E6-mediated c-fos/c-jun heter-
odimer formation in HPV-infected cells. This implies that
iron is necessary for c-fos/c-jun heterodimer formation. The
pr ecisetriggersofH 2O2 expressionaroundcervicalepithelial
cells are unknown, but it has been proposed that chronic
inﬂammation triggers the accumulation of macrophages in
the vicinity of the cervix, and that these cells subsequently
produce the antimicrobial molecule H2O2.
Finally, our data indicate that cervical cancer, the hall-
mark of which is HPV infection, is an EGFR-sensitive dis-
ease regardless of ligand-dependent or ligand-independent
stimulation. EGFR mAb therapies are eﬀective for treating
squamous cell carcinoma of the head and neck and are also
being evaluated in other HPV-associated tumors [29]. One
of the best-known mechanisms of EGFR mAb therapy resis-
tance is ligand-independent EGFR activation [30]. This was
observed in studies of squamous carcinoma cells (T-Hep3)
that naturally overexpress the uPA receptor, one of which
found that EGFR was activated by the uPA receptor in a
ligand-independent fashion, resulting in resistance to EGFR
mAb [31] .T h e r a p i e ss u c ha st h eu s eo fo-phenanthroline,
or alternative approaches such as the use of small molecule
EGFR tyrosine kinase inhibitors that block the intracellular
tyrosine kinase domain, could hold great potential for the
treatment of head and neck cancer.
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